1. Aurora kinase mRNA expression is reduced with increasing gestational age and in severe early onset fetal growth restriction. (June 2020) Authors: Beard, Sally; Pritchard, Natasha; Binder, Natalie; Schindler, Karen; De Alwis, Natasha; Kaitu'u-Lino, Tu'uhevaha J.; Tong, Stephen; Hannan, Natalie J. Journal: Placenta Issue: Volume 95(2020) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LOX-1 expression is reduced in placenta from cases of preeclampsia and in hypoxic cytotrophoblasts. (1st September 2021) Authors: de Alwis, Natasha; Beard, Sally; Binder, Natalie; Pritchard, Natasha; Kaitu'u-Lino, Tu'uhevaha; Walker, Susan; Stock, Owen; Groom, Katie; Petersen, Scott; Henry, Amanda; Said, Joanne; Seeho, Sean; Kane, Stefan; Tong, Stephen; Hannan, Natalie Journal: Placenta Issue: Volume 112(2021) Page Start: e83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. New generation antiplatelet therapies to prevent preeclampsia. (September 2016) Authors: Hannnan, Natalie; Kaitu'u-Lino, Tu'uhevaha; Beard, Sally; Binder, Natalie; Tong, Stephen Journal: Placenta Issue: Volume 45(2016:Sep.) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. New generation antiplatelet therapies to prevent preeclampsia. (September 2016) Authors: Hannnan, Natalie; Kaitu'u-Lino, Tu'uhevaha; Beard, Sally; Binder, Natalie; Tong, Stephen Journal: Placenta Issue: Volume 45(2016:Sep.) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nicotinamide and its effects on endothelial dysfunction and secretion of antiangiogenic factors by primary human placental cells and tissues. (June 2021) Authors: Brownfoot, Fiona; Binder, Natalie; Hastie, Roxanne; Harper, Alesia; Beard, Sally; Tuohey, Laura; Keenan, Emerson; Tong, Stephen; Hannan, Natalie Journal: Placenta Issue: Volume 109(2021) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity. Issue 6 (December 2015) Authors: Palmer, Kirsten R.; Kaitu'u-Lino, Tu'uhevaha J.; Hastie, Roxanne; Hannan, Natalie J.; Ye, Louie; Binder, Natalie; Cannon, Ping; Tuohey, Laura; Johns, Terrance G.; Shub, Alexis; Tong, Stephen Journal: Hypertension Issue: Volume 66:Issue 6(2015:Dec.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prasugrel reduces hypertension and vascular constriction in human and animal models of preeclampsia. (1st September 2021) Authors: de Alwis, Natasha; Mangwiro, Yeukai; Binder, Natalie; Beard, Sally; Tong, Stephen; Kaitu'u-Lino, Tu'uhevaha; Hannan, Natalie Journal: Placenta Issue: Volume 112(2021) Page Start: e24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction. Issue 3 (March 2017) Authors: Onda, Kenji; Tong, Stephen; Beard, Sally; Binder, Natalie; Muto, Masanaga; Senadheera, Sevvandi N.; Parry, Laura; Dilworth, Mark; Renshall, Lewis; Brownfoot, Fiona; Hastie, Roxanne; Tuohey, Laura; Palmer, Kirsten; Hirano, Toshihiko; Ikawa, Masahito; Kaitu'u-Lino, Tu'uhevaha; Hannan, Natalie J. Journal: Hypertension Issue: Volume 69:Issue 3(2017:Mar.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Proton Pump Inhibitors quench the pathophysiological characteristics of preeclampsia in both human and mouse models and represent an exciting novel candidate therapeutic. Issue 9 (September 2015) Authors: Onda, Kenji; Tong, Stephen; Binder, Natalie; Beard, Sally; Kaitu'u-Lino, Tu'uhevaha; Muto, Masanaga; Ikawa, Masahito; Dilworth, Mark; Renshall, Lewis; Senadheera, Sevvandi; Parry, Laura; Hastie, Roxanne; Brownfoot, Fiona; Tuohey, Laura; Palmer, Kirsten; Hannan, Natalie Journal: Placenta Issue: Volume 36:Issue 9(2015:Sep.) Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sofalcone Upregulates the Nuclear Factor (Erythroid-Derived 2)–Like 2/Heme Oxygenase-1 Pathway, Reduces Soluble fms–Like Tyrosine Kinase-1, and Quenches Endothelial Dysfunction. Issue 4 (April 2015) Authors: Onda, Kenji; Tong, Stephen; Nakahara, Anzu; Kondo, Mei; Monchusho, Hideaki; Hirano, Toshihiko; Kaitu'u-Lino, Tu'uhevaha; Beard, Sally; Binder, Natalie; Tuohey, Laura; Brownfoot, Fiona; Hannan, Natalie J. Journal: Hypertension Issue: Volume 65:Issue 4(2015:Apr.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗